Using mixtures of linoleic acid, a long-chain polyunsaturated fatty acid, and its monoglyceride in lipid-based formulations to increase drug loading and enhance aqueous microemulsification
Lade...
Autor:in (Körperschaft)
Publikationsdatum
2026
Typ der Arbeit
Studiengang
Typ
01A - Beitrag in wissenschaftlicher Zeitschrift
Herausgeber:innen
Herausgeber:in (Körperschaft)
Betreuer:in
Übergeordnetes Werk
International Journal of Pharmaceutics
Themenheft
DOI der Originalpublikation
Link
Zugehörige Forschungsdaten
Reihe / Serie
Reihennummer
Jahrgang / Band
Ausgabe / Nummer
Seiten / Dauer
127369
Patentnummer
Verlag / Herausgebende Institution
Elsevier
Verlagsort / Veranstaltungsort
Auflage
Version
Programmiersprache
Abtretungsempfänger:in
Praxispartner:in/Auftraggeber:in
Zusammenfassung
Although lipid-based formulations (LBFs) of self-emulsifying drug delivery systems (SEDDS) have been used for poorly water-soluble drugs, they have many limitations, the first being the low solubility of drugs in lipids, which limits drug loading in formulations, and the second being inadequate dispersion of formulations in the aqueous fluids of the human gastrointestinal tract (GIT). Large amounts of organic cosolvents and surfactants, up to 90% of the formulation, have been used to overcome these limitations. We previously demonstrated that the situation could be improved by using lipid digestion products (LDP), which consist of a 2:1 M ratio of long-chain fatty acids and monoglycerides, rather than lipids (triglycerides) themselves. The drug solubility and, therefore, drug loading in the formulations increased greatly in the presence of a long-chain fatty acid in the LDP. However, only one acid, oleic acid (OA), and its monoglyceride were used in those studies. To demonstrate the versatility of the approach, a different LDP, another acid, linoleic acid (LA), and its monoglyceride, glyceryl monolinoleate (GML), were used at a 2:1 M ratio in the present study, with clofazimine (CFZ) as the model. Although both OA and LA are C-18 fatty acids, the latter has two double bonds instead of one, which affects its physicochemical properties, such as pKa and molecular packing. Therefore, in addition to drug solubility, any additional effects of the extra double bond on LBFs were investigated. LA showed a high CFZ solubility of 480 mg/g, comparable to OA, and performed better in LBFs, with the developed formulation (100 mg/g) dispersing as microemulsions at intestinal pH, with particle sizes <250 nm, much smaller than the 400 nm observed for OA. High drug solubility and a smaller microemulsion particle size could increase in vivo drug release and absorption.
Schlagwörter
Fachgebiet (DDC)
Veranstaltung
Startdatum der Ausstellung
Enddatum der Ausstellung
Startdatum der Konferenz
Enddatum der Konferenz
Datum der letzten Prüfung
ISBN
ISSN
0378-5173
1873-3476
1873-3476
Sprache
Englisch
Während FHNW Zugehörigkeit erstellt
Ja
Zukunftsfelder FHNW
Publikationsstatus
Veröffentlicht
Begutachtung
peer-reviewed
Open Access-Status
Closed
Zitation
Kandagatla, H. P., Chowdary, N., Verbić, T. Ž., Avdeef, A., Savoy, A., Kuentz, M., & Serajuddin, A. T. M. (2026). Using mixtures of linoleic acid, a long-chain polyunsaturated fatty acid, and its monoglyceride in lipid-based formulations to increase drug loading and enhance aqueous microemulsification. International Journal of Pharmaceutics, 127369. https://doi.org/10.1016/j.ijpharm.2026.127369